Author:
Habib Rosemary,Nagrial Adnan,Micklethwaite Kenneth,Gowrishankar Kavitha
Publisher
Springer International Publishing
Reference168 articles.
1. Adachi K, Kano Y, Nagai T, Okuyama N, Sakoda Y, Tamada K (2018) IL-7 and CCL19 expression in CAR-T cells improves immune cell infiltration and CAR-T cell survival in the tumor. Nat Biotechnol 36:346–351
2. Alvarez-Vallina L, Hawkins RE (1996) Antigen-specific targeting of CD28-mediated T cell co-stimulation using chimeric single-chain antibody variable fragment-CD28 receptors. Eur J Immunol 26:2304–2309
3. Avanzi MP, Yeku O, Li X, Wijewarnasuriya DP, Van Leeuwen DG, Cheung K, Park H, Purdon TJ, Daniyan AF, Spitzer MH, Brentjens RJ (2018) Engineered tumor-targeted T cells mediate enhanced anti-tumor efficacy both directly and through activation of the endogenous immune system. Cell Rep 23:2130–2141
4. Baldan V, Ghongane P, Kokalaki E, Lim WC, Onuoha S, Cordoba SP, Thomas S, Pule M (2017) A dominant negative SHP-2 which abrogates PD-1 signalling pathways and restores function of cytotoxic CAR T cells. Blood 130:3190
5. Balkwill FR (2012) The chemokine system and cancer. J Pathol 226:148–157
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献